Constellium SE
(CSTM)
Price delayed 15 minutes
- Income Statement
- Blance Sheet
- Cash Flow Statement
Financial Statements
- Key Metrics
- Profitability
- Growth
- Valuation Multiples
- Operating Efficiency
- Liquidity & Solvency
- Cash
Ratio Analytics
My Watchlist
Log in to view your watchlist.
Growth Rates
2021 | 2020 | ||||
---|---|---|---|---|---|
1-Year Growth: | |||||
Revenue | 25.99% | -17.34% | |||
Net Income | - | -128.81% | |||
Operating Income | 287.2% | -50.98% | |||
Total Assets | 11.99% | -1.31% | |||
Stockholders Equity | - | - | |||
Intangibles & Goodwill | 6.49% | -8.95% | |||
Capex | - | - | |||
Free Cash Flows (Unlevered) | 14.15% | -35.58% | |||
Free Cash Flows (Levered) | -452.11% | -79.74% | |||
R&D Expense | - | -18.75% | |||
Dividends | - | - | |||
 | |||||
3-Year Growth: | |||||
Revenue | 8.2% | -6.76% | |||
Net Income | 36.7% | - | |||
Operating Income | 19.8% | -61.06% | |||
Total Assets | 18.53% | 11.26% | |||
Stockholders Equity | - | - | |||
Intangibles & Goodwill | 3.46% | 1.49% | |||
Capex | - | - | |||
Free Cash Flows (Unlevered) | 71.72% | 18.35% | |||
Free Cash Flows (Levered) | -281.82% | - | |||
R&D Expense | -2.5% | 8.33% | |||
Dividends | - | - | |||
 | |||||
5-Year Growth: | |||||
Revenue | 29.71% | -5.24% | |||
Net Income | - | - | |||
Operating Income | 96.75% | - | |||
Total Assets | 22.1% | 13.81% | |||
Stockholders Equity | - | - | |||
Intangibles & Goodwill | -5.04% | -8.25% | |||
Capex | - | - | |||
Free Cash Flows (Unlevered) | 39.57% | -57.32% | |||
Free Cash Flows (Levered) | -343.9% | -85.77% | |||
R&D Expense | 21.88% | 11.43% | |||
Dividends | - | - |